8.5313
Schlusskurs vom Vortag:
$8.26
Offen:
$8.38
24-Stunden-Volumen:
296.89K
Relative Volume:
0.75
Marktkapitalisierung:
$1.22B
Einnahmen:
$6.32B
Nettoeinkommen (Verlust:
$230.14M
KGV:
8.8886
EPS:
0.9598
Netto-Cashflow:
$256.03M
1W Leistung:
-0.93%
1M Leistung:
-9.37%
6M Leistung:
-35.77%
1J Leistung:
-38.11%
Ardent Health Inc Stock (ARDT) Company Profile
Firmenname
Ardent Health Inc
Sektor
Branche
Telefon
(615) 296-3000
Adresse
340 SEVEN SPRINGS WAY, BRENTWOOD
Compare ARDT vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ARDT
Ardent Health Inc
|
8.54 | 1.18B | 6.32B | 230.14M | 256.03M | 0.9598 |
|
HCA
Hca Healthcare Inc
|
473.67 | 104.59B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
189.03 | 16.35B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.54 | 12.41B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
203.23 | 11.65B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
179.41 | 11.12B | 17.36B | 1.51B | 849.25M | 23.15 |
Ardent Health Inc Stock (ARDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-17 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-09-10 | Eingeleitet | UBS | Buy |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-12 | Eingeleitet | BofA Securities | Buy |
| 2024-08-12 | Eingeleitet | Citigroup | Buy |
| 2024-08-12 | Eingeleitet | JP Morgan | Neutral |
| 2024-08-12 | Eingeleitet | Leerink Partners | Outperform |
| 2024-08-12 | Eingeleitet | Loop Capital | Buy |
| 2024-08-12 | Eingeleitet | Mizuho | Outperform |
| 2024-08-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-08-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-12 | Eingeleitet | Stephens | Overweight |
| 2024-08-12 | Eingeleitet | Truist | Buy |
Alle ansehen
Ardent Health Inc Aktie (ARDT) Neueste Nachrichten
Trump's Medicaid Rollback Could Put Hundreds Of Hospitals In Peril, New Report Finds - Benzinga
Ardent Health announces termination of president of hospital services - Nashville Post
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-03-29 | Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NYSE:ARDT | Press Release - Stockhouse
Goldman Sachs Initiates Coverage of Ardent Health (ARDT) with Neutral Recommendation - MSN
The Bull Case For Ardent Health (ARDT) Could Change Following President Of Hospital Services Exit - simplywall.st
Ardent Health, Inc. Files Form 8-K With SEC Detailing Company Information and Stock Listing - Minichart
Ardent Health Announces Leadership Change in Hospital Services - TipRanks
Ardent Health (ARDT) hospital services president exits under severance plan - Stock Titan
Ardent Health, Inc. Announces Departure of Ethan Chernin as President, Hospital Services, Effective March 24, 2026 - marketscreener.com
Ardent Health (NYSE:ARDT) Stock Rating Upgraded by Zacks Research - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Investors to Connect - ACCESS Newswire
Ardent Health 4Q25 slides: strong year ends with challenging quarter - Investing.com
Earnings call transcript: Ardent Health’s Q4 2025 revenue hits $1.61B - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ARDT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Stockholders to Connect - ACCESS Newswire
2026-03-19 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Stockholders to Connect | NYSE:ARDT | Press Release - Stockhouse
Kuehn Law Encourages Investors of Ardent Health, Inc. to Contact Law Firm - GuruFocus
Tranche Update on Ardent Health, Inc.'s Equity Buyback Plan announced on November 18, 2025. - marketscreener.com
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Gains Recap: Is Ardent Health Partners Inc stock overvalued or fairly priced2026 Momentum & Reliable Entry Point Alerts - baoquankhu1.vn
Ardent Health, Inc. Common Stock (NY: ARDT - The Chronicle-Journal
Decoding Ardent Health Inc (ARDT): A Strategic SWOT Insight - GuruFocus
Ardent 2025 10-K: $6.32B Revenue; Net Income $230.1M - TradingView
Ardent Health (ARDT) outlines hospital JV network and quality gains - Stock Titan
RBC Capital lowers Ardent Health stock price target on revised estimates - Investing.com Australia
RBC Capital lowers Ardent Health stock price target on revised estimates By Investing.com - Investing.com India
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
2026-03-15 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Stockholders to Learn More About the Investigation | NYSE:ARDT | Press Release - Stockhouse
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - Nasdaq
Ardent Health (ARDT) EVP awarded 34,733 performance-based shares - Stock Titan
Ardent Health (ARDT) CFO receives 61,081 performance-based stock units in grant - Stock Titan
Ardent Health (ARDT) president granted 32,408 performance-based shares - Stock Titan
Ardent Health (ARDT) CEO receives 195,316-share performance stock award - Stock Titan
Ardent Health (ARDT) SVP & CAO awarded 8,859 performance-based shares - Stock Titan
Pier Capital LLC Acquires 145,703 Shares of Ardent Health, Inc. $ARDT - MarketBeat
Auna's Mexico Operations Stabilize in Q4: How the Path Ahead Looks - TradingView
Ardent Health Partners, Inc. (ARDT) Receives a Buy from RBC Capital - The Globe and Mail
Ardent Health Earnings Call: Strength Today, Caution Ahead - TipRanks
RBC Cuts Price Target on Ardent Health to $13 From $14, Keeps Outperform Rating - marketscreener.com
Ardent Health, Inc. (NYSE:ARDT) Receives Average Rating of "Hold" from Analysts - MarketBeat
Class Action Filed Against Ardent Health, Inc. (ARDT)March 9, 2026 Deadline to JoinContact The Gross Law Firm - marketscreener.com
Levi & Korsinsky Notifies Ardent Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ARDT - GlobeNewswire
ARDT CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Ardent Investors of the Securities Class Action Lawsuit Deadline on March 9, 2026 - 巴士的報
ARDT DEADLINE ALERT: Ardent Health (ARDT) Investors Alerted - GlobeNewswire
ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
KeyBanc reiterates Sector Weight on Ardent Health stock By Investing.com - Investing.com Australia
KeyBanc reiterates Sector Weight on Ardent Health stock - Investing.com
Assessing Ardent Health (ARDT) Valuation As Shares Face Recent Short Term Weakness - Yahoo Finance
Finanzdaten der Ardent Health Inc-Aktie (ARDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):